The International Society of Blood Transfusion (ISBT) Public Health Research Toolkit: A report from the Surveillance, Risk Assessment and Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party.

Publisher: Blackwell Science Country of Publication: England NLM ID: 0413606 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0410 (Electronic) Linking ISSN: 00429007 NLM ISO Abbreviation: Vox Sang Subsets: MEDLINE

Publication: 2001- : Oxford, UK : Blackwell Science
Original Publication: Basel : Karger

COVID-19*/epidemiology ; Blood Transfusion*/methods ; Blood Donors* ; Public Health*; Transfusion Reaction/epidemiology ; Transfusion Reaction/prevention & control ; Blood-Borne Infections/prevention & control ; Blood-Borne Infections/epidemiology ; Humans ; Risk Assessment ; SARS-CoV-2 ; Pandemics

Background and Objectives: Data provided from blood donors have contributed to the understanding of public health epidemiology and policy decisions. A recent example was during the severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) pandemic when blood services monitored the seroprevalence in blood donors. Based on this experience, blood services have the opportunity to expand their role and participate in public health surveillance and research. The aim of this report is to share available resources to assist blood services in this area.
Materials and Methods: The Surveillance, Risk Assessment and Policy (SRAP) Sub-group of the International Society of Blood Transfusion (ISBT) Transfusion Transmitted Infectious Diseases (TTID) Working Party developed a Public Health Research Toolkit to assist blood services and researchers interested in expanding their role in public health research.
Results: The ISBT Public Health Research Toolkit provides resources for what blood services can offer to public health, examples of donor research studies, the utility of donor data and website links to public health agencies. The toolkit includes a customizable template for those interested in establishing and managing a biobank.
Conclusion: The ISBT Public Health Research Toolkit includes resources to increase the recognition of the role blood donors can play in public health and to help blood services gain commitment and funding from various agencies for new research and surveillance.
(© 2024 The Author(s). Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion.)

Alter HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG, et al. Posttransfusion hepatitis after exclusion of commercial and hepatitis‐B antigen‐positive donors. Ann Intern Med. 1972;77:691–699.
Bloch EM, Busch MP, Corash LM, Dodd R, Hailu B, Kleinman S, et al. Leveraging donor populations to study the epidemiology and pathogenesis of transfusion‐transmitted and emerging infectious diseases. Transfus Med Rev. 2023;37:150769.
Mansuy JM, Gallian P, Dimeglio C, Saune K, Arnaud C, Pelletier B, et al. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology. 2016;63:1145–1154.
Zhao J, Rostgaard K, Hjalgrim H, Edgren G. The Swedish Scandinavian Donations and Transfusions Database (SCANDAT3‐S)—50 years of donor and recipient follow‐up. Transfusion. 2020;60:3019–3027.
Erikstrup C, Sørensen E, Nielsen KR, Bruun MT, Petersen MS, Rostgaard K, et al. Cohort profile: the Danish Blood Donor Study. Int J Epidemiol. 2022;52:e162–e171.
Atsma F, de Vegt F. The healthy donor effect: a matter of selection bias and confounding. Transfusion. 2011;51:1883–1885.
O'Brien SF, Lieshout‐Krikke RW, Lewin A, Erikstrup C, Steele WR, Uzicanin S, et al. Research initiatives of blood services worldwide in response to the COVID‐19 pandemic. Vox Sang. 2021;116:296–304.
Lewin A, Osiowy C, Erikstrup C, Custer B, Renaud C, Tiberghien P, et al. Research partnerships between blood services and public health authorities: an international, cross‐sectional survey. Vox Sang. 2022;117:1368–1374.
O'Brien SF, Drews SJ, Lewin A, Russell A, Davison K, Goldman M, et al. How do we decide how representative our donors are for public health surveillance? Transfusion. 2022;62:2431–2437.
Singh S, Cadigan RJ, Moodley K. Challenges to biobanking in LMICs during COVID‐19: time to reconceptualise research ethics guidance for pandemics and public health emergencies? J Med Ethics. 2022;48:466–471.
Héma‐Quebec. Management and governance framework for the Plasma Donor Biobank—Héma‐Québec. Tracking plasma donors—impact on the immune response from the vaccination against SARS‐CoV‐2 that causes COVID‐19—building a longitudinal cohort. 2023 Available from: https://www.hema-quebec.qc.ca/userfiles/file/media/anglais/rd/Governance_Framework_Plasma_Donor_Biobank_HQ.pdf. Last accessed 21 Mar 2024.

Keywords: biobanks; donors; public health; research; toolkit

Date Created: 20240725 Date Completed: 20241008 Latest Revision: 20241008

20260130

10.1111/vox.13713

39054253